CRESCENT CAP.BDC DL-,001

Closed-end funds are special income vehicles, with many positive aspects and just as many weaknesses that take time to be properly understood and evaluated. I discovered their existence about ten years ago, and over time, I became convinced of their worth by developing a personal method of selection based mainly on NAV performance. This is an analytical, data-driven approach which I then extended to other types of securities in my portfolio, namely ETFs and BDCs.» Mehr auf seekingalpha.com

The recent rally in small-cap stocks indicates strong market confidence toward 2025, also making Crescent Capital BDC a compelling income investment. CCAP should benefit from a pro-small business tax policy and a favorable market environment, offering a 9.7% dividend yield for income seekers. Comparing CCAP with RVT shows similar total returns, with CCAP outperforming since inception, suggesting CCAP's strong performance in a rate-cut cycle.» Mehr auf seekingalpha.com

Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is concentrated in health care and software, with 97% of debt investments on a floating rate basis. The rate of non-accruals still remains low, showing portfolio company resilience. This highlights CCAP's high-quality underwriting and financial health.» Mehr auf seekingalpha.com